Sotagliflozin is a dual sodium-glucose cotransporter 1 and 2 (SGLT1/2) inhibitor used in the management of type 2 diabetes mellitus to help control blood glucose levels by reducing intestinal and renal… Read more



Sotagliflozin is a dual sodium-glucose cotransporter 1 and 2 (SGLT1/2) inhibitor used in the management of type 2 diabetes mellitus to help control blood glucose levels by reducing intestinal and renal glucose absorption. To support rigorous analytical testing and quality control within pharmaceutical laboratories, this category provides a comprehensive range of high-quality reference standards, including the active pharmaceutical ingredient, synthetic impurities, degradation products, and stable isotope labelled compounds. These materials are essential for accurate impurity profiling and method validation, enabling chemists to identify and quantify potential process-related impurities or metabolites during the manufacturing and stability testing processes. By utilizing these precise reference materials, researchers can ensure compliance with regulatory standards and maintain consistent product quality throughout the drug development lifecycle.